Jordanian Industry: Growth in exports of therapeutic industries and medical supplies by 6.3%

The representative of the therapeutic industries and medical supplies sector in the Jordan Chamber of Industry, Fadi Al-Atrash, confirmed that the sector’s exports grew significantly during the past year 2023, by a rate of 6.3%.

Al-Atrash said that the exports of the three sub-sectors (human medicines, veterinary medicines, pesticides, and medical supplies) amounted to about 736 million dinars last year, compared to 692 million dinars in 2022, ranking sixth among other sectors in terms of exports and fifth in terms of positive growth.

The therapeutic industries and medical supplies sector includes 151 establishments, with a registered capital of about 341 million dinars, while the number of Jordanian factories outside the Kingdom is 15 factories, in Saudi Arabia, Algeria, Egypt, Morocco and Sudan.

He added that the human pharmaceutical sector constituted the largest share of exports during the past year, with a value of 620 million dinars and a growth rate of 19 percent, compared to 2022, according to statistical figures from the three chambers of industry in the Kingdom.

He pointed to the support that the sector received from His Majesty King Abdullah II, and His Majesty’s meeting with representatives of the pharmaceutical sector and his emphasis on the importance of maintaining Jordan’s pioneering role and leadership in the field of pharmaceutical production and the necessity of cooperation between institutions, to overcome any obstacles that hinder its work, and to research and address the obstacles that limit its progress and renaissance. .

He stressed that including the sector in the vision of economic modernization had a significant impact in facilitating and facilitating many procedures and accelerating registration processes, which had a direct and positive impact on export growth.

The economic modernization vision aspires to advance the sector so that Jordan becomes a regional center for pharmaceutical products, and the sector enjoys a high added value of up to 55 percent of total production, i.e. a value of 850 million dinars.

The vision seeks to raise the sector’s exports to 2.1 billion dinars, employ 16,000 people, and increase the contribution to the gross domestic product to reach 1.7 billion dinars by 2033.

It also seeks to attract investments to the sector estimated at approximately 1.1 billion dinars over ten years, with the aim of improving its business to become a regional center for pharmaceutical products, through the use of technologies and the development of new drugs, focusing on expansion and entry into new markets, and achieving pharmaceutical security for Jordan and the region.

He pointed to the continuous support provided by the Food and Drug Administration to the sector, as many processes related to registering local medicines were automated and analysis was separated from registration, which contributed to accelerating the registration of local medicines and was reflected in exports, while many contemporary laws, legislation, and instructions were provided that would develop Industry and development.

Al-Atrash pointed to the local and international conferences and exhibitions in which the sector’s companies participated, to highlight the importance of Jordan as a regional center for the pharmaceutical industry in the region in fulfillment of the aspirations of His Majesty the King, including: The Third International Pharmaceutical Conference, organized by the Food and Drug Administration under the title (Royal Visions in Achieving Pharmaceutical Security), which formed The basic foundation for supporting innovation and creativity in the pharmaceutical industry,

He pointed to the Arab Pharma Expo in its fifth session, which was organized by the Arab Federation of Pharmaceutical Manufacturers in Amman with the participation of 250 companies from various countries of the world, and KIHE 2023 in Kazakhstan, in addition to the CPHI exhibition in Spain, and many other exhibitions.

He stated that the sector, with its three sub-sectors, witnessed many investments last year, most notably the establishment of a new pharmaceutical factory in the Mobus area, which obtained a Good Manufacturing Certificate, and will work to provide new jobs, in addition to the opening of new production lines in other factories concerned with the manufacture of animal vaccines, vitamins, nutritional supplements, and pharmaceutical forms. New and innovative.